Animal & Veterinary

Swine


Breeding Swine
Feral Swine
Finishing Swine
Growing Swine
Piglets
Swine


Marketing Status The following guide explains the marketing status categories used in the tables below:

  • OTC - Product is in over-the-counter marketing status and is not impacted by Guidance for Industry #213 (GFI #213)
  • VFD - Product is in Veterinary Feed Directive Status.

Breeding Swine

Active Ingredient Proprietary Name NADA/ANADA Label Type Indications Marketing Status
Bacitracin Methylene Disalicylate BMD 30 N046-592 Type B For control of clostridial enteritis caused by Clostridium perfringens in suckling piglets when fed to sows from 14 days before through 21 days after farrowing on premises with a history of clostridial scours. OTC
Bacitracin Methylene Disalicylate BMD 30 N046-592 Type C For control of clostridial enteritis caused by Clostridium perfringens in suckling piglets when fed to sows from 14 days before through 21 days after farrowing on premises with a history of clostridial scours. OTC
Chlortetracycline CHLORMAX N046-699 Type C Breeding swine: For control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline CHLORATET N048-480 Type B Breeding swine: For control of leptospirosis (reducing the incidence of abortion and shedding of Leptospirae) caused by Leptospira pomona susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline CHLORATET N048-480 Type C Breeding swine: For control of leptospirosis (reducing the incidence of abortion and shedding of Leptospirae) caused by Leptospira pomona susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline AUREOMYCIN N048-761 Type B For control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline in breeding swine. VFD (Effective 1/1/17)
Chlortetracycline AUREOMYCIN N048-761 Type C For control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline in breeding swine. VFD (Effective 1/1/17)
Chlortetracycline CLTC N092-286 Type C For breeding swine for control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline DERACIN A200-510 Type B For control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline in breeding swine. VFD (Effective 1/1/17)
Chlortetracycline DERACIN A200-510 Type C For control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline in breeding swine. VFD (Effective 1/1/17)
Ivermectin, Bacitracin Methylene Disalicylate BMD, IVOMEC N141-097 Type C For the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, lice, and mange mites.
For control of clostridial enteritis caused by C. perfringens in suckling piglets. 
OTC
Neomycin Sulfate and Oxytetracycline NEO-OXTC N138-939 Type C For control and treatment of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline. VFD (Effective 1/1/17)

Back to the top

Feral Swine

Active Ingredient Proprietary Name NADA/ANADA Label Type Indications Marketing Status
Fenbendazole SAFE-GUARD N131-675 Type C  For the control and removal of kidney worms (Stephanurus dentatus), round worms (Ascaris suum), and nodular worms (Oesophagostomum dentatum) OTC

Back to the top

 Finishing Swine

Active Ingredient Proprietary Name NADA/ANADA Label Type Indications Marketing Status
Ractopamine and Tylosin PAYLEAN, TYLAN N141-172 Type B For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs...; for control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Ractopamine and Tylosin PAYLEAN, TYLAN N141-172 Type B For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs...; and for control of porcine proliferative enteropathies  associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Ractopamine and Tylosin PAYLEAN, TYLAN N141-172 Type B For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, ...; the treatment and control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Ractopamine and Tylosin PAYLEAN, TYLAN N141-172 Type C For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, ...; for control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Ractopamine and Tylosin PAYLEAN, TYLAN N141-172 Type C For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs... and for control of porcine proliferative enteropathies associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Ractopamine and Tylosin PAYLEAN, TYLAN N141-172 Type C For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs...; for treatment and control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Ractopamine and Tylosin PAYLEAN, TYLOVET A200-530 Type B For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferafive enteropathies (PPE, ileitis) associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Ractopamine and Tylosin PAYLEAN, TYLOVET A200-530 Type C For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Ractopamine and Tylosin PAYLEAN, TYLOVET A200-530 Type B For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Ractopamine and Tylosin PAYLEAN, TYLOVET A200-530 Type B For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for the treatment and control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Ractopamine and Tylosin PAYLEAN, TYLOVET A200-530 Type C For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for treatment and control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Ractopamine and Tylosin PAYLEAN, TYLOVET A200-530 Type C For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; and for control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Ractopamine and Tylosin ENGAIN, TYLAN A200-558 Type B For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Ractopamine and Tylosin ENGAIN, TYLAN A200-558 Type C For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Ractopamine and Tylosin ENGAIN, TYLAN A200-558 Type B For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with
Lawsonia intracellularis.
VFD (Effective 1/1/17)
Ractopamine and Tylosin ENGAIN, TYLAN A200-558 Type C For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with
Lawsonia intracellularis.
VFD (Effective 1/1/17)
Ractopamine and Tylosin ENGAIN, TYLAN A200-558 Type B For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for the treatment and control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Ractopamine and Tylosin ENGAIN, TYLAN A200-558 Type C For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for the treatment and control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Ractopamine and Tylosin ENGAIN, TYLOVET A200-584 Type B For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Ractopamine and Tylosin ENGAIN, TYLOVET A200-584 Type B For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with
Lawsonia intracellularis.
VFD (Effective 1/1/17)
Ractopamine and Tylosin ENGAIN, TYLOVET A200-584 Type B For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for the treatment and control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Ractopamine and Tylosin ENGAIN, TYLOVET A200-584 Type C For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for treatment and control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Ractopamine and Tylosin ENGAIN, TYLOVET A200-584 Type C For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Ractopamine and Tylosin ENGAIN, TYLOVET A200-584 Type C For increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter, and for control of porcine proliferative enteropathies (PPE, ileitis) associated with
Lawsonia intracellularis.
VFD (Effective 1/1/17)

Back to the top

Growing Swine

Active Ingredient Proprietary Name NADA/ANADA Label Type Indications Marketing Status
Chlortetracycline CHLORMAX N046-699 Type C For an increased rate of weight gain and improved feed efficiency in growing swine. As of 1/1/17, this use is no longer approved
Chlortetracycline AUREOMYCIN N048-761 Type B For increased rate of weight gain and improved feed efficiency in growing swine. As of 1/1/17, this use is no longer approved
Chlortetracycline AUREOMYCIN N048-761 Type C For increased rate of weight gain and improved feed efficiency in growing swine. As of 1/1/17, this use is no longer approved

Back to the top

Piglets

Active Ingredient Proprietary Name NADA/ANADA Label Type Indications Marketing Status
Ivermectin, Bacitracin Methylene Disalicylate BMD, IVOMEC N141-097 Type B For the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, threadworms, lice and mange mites.
For control of clostridial enteritis caused by C. perfringens in suckling piglets.
OTC

Back to the top

Swine

Active Ingredient Proprietary Name NADA/ANADA Label Type Indications Marketing Status/Posting Date
Apramycin APRALAN N126-050 Type C For control of porcine colibacillosis (weanling pig scours) caused by susceptible strains of Escherichia coli. VFD (Effective 1/1/17)
Avilamycin KAVAULT N141-438 Type C For the reduction in incidence and overall severity of diarrhea in the presence of pathogenic
Escherischia coli in groups of weaned pigs.
VFD
Bacitracin Methylene Disalicylate BMD N046-592 Type B For increased rate of weight gain and improved feed efficiency in growing and finishing swine. OTC
Bacitracin Methylene Disalicylate BMD N046-592 Type C For increased rate of weight gain and improved feed efficiency in growing and finishing swine. OTC
Bacitracin Methylene Disalicylate BMD N046-592 Type B For control of swine dysentery associated with Treponema hyodysenteriae on premises with a history of swine dysentery but where signs of the disease have not yet occurred; or following an approved treatment of the disease condition in growing and finishing swine weighing up to 250 pounds. OTC
Bacitracin Methylene Disalicylate BMD N046-592 Type C For control of swine dysentery associated with Treponema hyodysenteriae on premises with a history of swine dysentery but where signs of the disease have not yet occurred; or following an approved treatment of the disease condition in growing and finishing swine weighing up to 250 pounds. OTC
Bacitracin Zinc ALBAC A200-223 Type B For increased rate of weight gain and improved feed efficiency in growing and finishing swine. OTC
Bacitracin Zinc ALBAC A200-223 Type C For increased rate of weight gain and improved feed efficiency in growing and finishing swine. OTC
Carbadox MECADOX N041-061 Type B For control of swine dysentery (vibrionic dysentery, bloody scours by hemorrhagic dysentery); control of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis); increased rate of weight gain and improved feed efficiency. OTC
Carbadox MECADOX N041-061 Type B For increased rate of weight gain and improved feed efficiency. OTC
Carbadox MECADOX N041-061 Type C For control of swine dysentery (vibrionic dysentery, bloody scours of hemorrhagic dysentery); control of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis); increased rate of weight gain and improved feed efficiency. OTC
Carbadox MECADOX N041-061 Type C For increased rate of weight gain and improved feed efficiency. OTC
Carbadox and Oxytetracycline MECADOX, TERRAMYCIN N141-211 Type C For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis susceptible to oxytetracycline and treatment of bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline and increased rate of weight gain and improved feed efficiency. VFD (Effective 1/1/17)
Carbadox and Pyrantel tartrate MECADOX, BANMINTH N092-955 Type C Control of swine dysentery (vibrionic dysentery, bloody scours or hemorrhagic dysentery); control of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis); aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; aid in the prevention of establishment of nodular worm (Oesophagostomum spp.) infections in swine. OTC
Chlortetracycline CHLORMAX N046-699 Type B For control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis... For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida organisms. VFD (Effective 1/1/17)
Chlortetracycline CHLORMAX N046-699 Type C For reducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci. VFD (Effective 1/1/17)
Chlortetracycline CHLORMAX N046-699 Type C For control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis...For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida organisms. VFD (Effective 1/1/17)
Chlortetracycline AUREOMYCIN N048-761 Type B For control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracycline. For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline AUREOMYCIN N048-761 Type C For control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracycline. For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline AUREOMYCIN N048-761 Type B For reducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci susceptible to chlortetracycline in swine. VFD (Effective 1/1/17)
Chlortetracycline AUREOMYCIN N048-761 Type C For reducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci susceptible to chlortetracycline in swine. VFD (Effective 1/1/17)
Chlortetracycline CHLORATET N048-480 Type B Treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline CHLORATET N048-480 Type C Treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline CHLORATET N048-480 Type B For reducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E. Streptococci susceptible to chlortetracycline VFD (Effective 1/1/17)
Chlortetracycline CHLORATET N048-480 Type C For reducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E. Streptococci susceptible to chlortetracycline VFD (Effective 1/1/17)
Chlortetracycline CLTC N092-286 Type C For swine for treatment of bacterial enteritis caused by  E. coli and S. choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline VFD (Effective 1/1/17)
Chlortetracycline CLTC N092-286 Type C For swine for reducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline PENNCHLOR N138-935 Type B For use in manufacturing medicated swine feed. VFD (Effective 1/1/17)
Chlortetracycline PENNCHLOR N138-935 Type C For reducing the incidence of cervical lymphadenitis (jowl abscesses caused by  Group E. Streptococci susceptible to chlortetracycline VFD (Effective 1/1/17)
Chlortetracycline PENNCHLOR N138-935 Type C For the treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline PENNCHLOR N138-935 Type C For the control of leptospirosis (reducing the incidence of abortions and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline in breeding swine. VFD (Effective 1/1/17)
Chlortetracycline DERACIN A200-510 Type B For control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracycline. For treatment of bacterial enteritis caused by  Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline DERACIN A200-510 Type C For control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracycline. For treatment of bacterial enteritis caused by  Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline DERACIN A200-510 Type B For reduction in the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci susceptible to chlortetracycline in swine. VFD (Effective 1/1/17)
Chlortetracycline DERACIN A200-510 Type C For reduction in the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci susceptible to chlortetracycline in swine. VFD (Effective 1/1/17)
Chlortetracycline and Bacitracin Methylene Disalicylate BMD, CHLORMAX N141-059 Type B For increased rate of weight gain and improved feed efficiency; for treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline, and for control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracyline. VFD (Effective 1/1/17)
Chlortetracycline and Bacitracin Methylene Disalicylate BMD, CHLORMAX N141-059 Type B For increased rate of weight gain and improved feed efficiency; for treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline, and for control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracyline. VFD (Effective 1/1/17)
Chlortetracycline and Bacitracin Methylene Disalicylate BMD, CHLORMAX N141-059 Type C For increased rate of weight gain and improved feed efficiency; for treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline, and for control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracyline. VFD (Effective 1/1/17)
Chlortetracycline and Bacitracin Methylene Disalicylate BMD, AUREOMYCIN A200-242 Type B For increased rate of weight gain and improved feed efficiency; for treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline, and for control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracyline. VFD (Effective 1/1/17)
Chlortetracycline and Bacitracin Methylene Disalicylate BMD, AUREOMYCIN A200-242 Type B For increased rate of weight gain and improved feed efficiency; for treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline, and for control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracyline. VFD (Effective 1/1/17)
Chlortetracycline and Bacitracin Methylene Disalicylate BMD, AUREOMYCIN A200-242 Type C For increased rate of weight gain and improved feed efficiency; for treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline, and for control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracyline. VFD (Effective 1/1/17)
Chlortetracycline and Bacitracin Methylene Disalicylate PENNCHLOR, BMD A200-358 Type B For increased rate of weight gain and improved feed efficiency; for treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline and Bacitracin Methylene Disalicylate PENNCHLOR, BMD A200-358 Type C For increased rate of weight gain and improved feed efficiency; for treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline and Sulfamethazine AUREOMIX N035-688 Type B For reduction of the incidence of cervical abscesses; treatment of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis and vibrionic dysentery); prevention of these diseases during times of stress; and maintenance of weight gains in the presence of atrophic rhinitis. VFD (Effective 1/1/17)
Chlortetracycline and Sulfamethazine AUREOMIX N035-688 Type C For reduction of the incidence of cervical abscesses; treatment of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis and vibrionic dysentery); prevention of these diseases during times of stress; and maintenance of weight gains in the presence of atrophic rhinitis. VFD (Effective 1/1/17)
Chlortetracycline and Sulfamethazine PENNCHLOR N138-934 Type B For reduction of the incidence of cervical abscesses, treatment of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis and vibrionic dysentery); prevention of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis and vibrionic dysentery) during time of stress; maintenance of weight gains in the presence of atrophic rhinitis. VFD (Effective 1/1/17)
Chlortetracycline and Sulfamethazine PENNCHLOR N138-934 Type C For reduction of the incidence of cervical abscesses, treatment of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis and vibrionic dysentery); prevention of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis and vibrionic dysentery) during time of stress; maintenance of weight gains in the presence of atrophic rhinitis. VFD (Effective 1/1/17)
Florfenicol NUFLOR N141-264 Type B For the control of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Streptococcus suis, and Bordetella bronchiseptica in groups of swine in buildings experiencing an outbreak of SRD. VFD
Florfenicol NUFLOR N141-264 Type C For the control of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Streptococcus suis, and Bordetella bronchiseptica in groups of swine in buildings experiencing an outbreak of SRD. VFD
Hygromycin HYGROMIX N010-918 Type B As an aid in the control of infections of the following intestinal parasites: Large roundworms (Ascaris suis), nodular worms (Oesophagostomum dentatum), and whipworms (Trichuris suis). VFD (Effective 1/1/17)
Hygromycin HYGROMIX N010-918 Type C As an aid in the control of infections of the following intestinal parasites: Large roundworms (Ascaris suis), nodular worms (Oesophagostomum dentatum), and whipworms (Trichuris suis). VFD (Effective 1/1/17)
Ivermectin, Bacitracin Methylene Disalicylate BMD, IVOMEC N141-097 Type C For the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, threadworms, lice and mange mites.
For increased rate of weight gain and improved feed efficiency in growing finishing swine.
OTC
Ivermectin, Bacitracin Methylene Disalicylate BMD, IVOMEC N141-097 Type B For the treatment and control of gastrointestinal roundworms, kidneyworms, lice, and mange mites.
For increased rate of weight gain and improved feed efficiency in growing and finishing swine.
OTC
Ivermectin, Bacitracin Methylene Disalicylate BMD, IVOMEC N141-097 Type B For the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, lice, and mange mites.
For increased rate of weight gain and improved feed efficiency in growing and finishing swine.
OTC
Ivermectin, Bacitracin Methylene Disalicylate BMD, IVOMEC N141-097 Type C For the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, lice, and mange mites.
For control of swine dysentery associated with Treponema hyodysenteriae on premises with a history of swine dysentery but where signs of disease have not yet occurred; or following an approved treatment of the disease condition.
OTC
Ivermectin, Bacitracin Methylene Disalicylate BMD, IVOMEC N141-097 Type C For the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, lice, and mange mites.
For increased rate of weight gain and improved feed efficiency in growing and finishing swine. 
OTC
Ivermectin, Bacitracin Methylene Disalicylate BMD, IVOMEC N141-097 Type B For the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, lice, and mange mites.
For control of swine dysentery associated with Treponema hyodysenteriae on premises with a history of swine dysentery but where signs of the disease have not yet occurred; or following an approved treatment of the disease condition.
OTC
Ivermectin and Lincomycin IVOMEC, LINCOMIX N141-054 Type C

For the treatment and control of gastrointestinal roundworms (Ascaris suum, adults and fourth-stage larvae; Ascarops strongylina, adults; Hyostrongylus rubidus, adults and fourth-stage larvae; Oesophagostomum spp., adults and fourth-stage larvae), kidneyworms (Stephanurus dentatus, adults and fourth-stage larvae), lungworms (Metastrongylus spp., adults), lice (Haematopinus suis) and mange mites (Sarcoptes scabiei var. suis). 

Treatment of swine dysentery.

VFD (Effective 1/1/17)
Ivermectin, Lincomycin IVOMEC, LINCOMIX N141-054 Type B For the treatment and control of gastrointestinal roundworms (Ascaris suum, adults and fourth-stage larvae; Ascarops strongylina, adults; Hyostrongylus rubidus, adults and fourth-stage larvae; Oesophagostomum spp., adults and fourth-stage larvae), kidneyworms (Stephanurus dentatus, adults and fourth-stage larvae), lungworms (Metastrongylus spp., adults), lice (Haematopinus suis) and mange mites (Sarcoptes scabiei var. suis).
For reduction in the severity of swine mycoplasmal pneumonia caused by Mycoplasma hyopneumoniae.
VFD (Effective 1/1/17)
Ivermectin, Lincomycin IVOMEC, LINCOMIX N141-054 Type B

For the treatment and control of gastrointestinal roundworms (Ascaris suum, adults and fourth-stage larvae; Ascarops strongylina, adults; Hyostrongylus rubidus, adults and fourth-stage larvae; Oesophagostomum spp., adults and fourth-stage larvae), kidneyworms (Stephanurus dentatus, adults and fourth-stage larvae), lungworms (Metastrongylus spp., adults), lice (Haematopinus suis) and mange mites (Sarcoptes scabiei var. suis).

For control of swine dysentery

VFD (Effective 1/1/17)
Ivermectin, Lincomycin IVOMEC, LINCOMIX N141-054 Type C For the treatment and control of gastrointestinal roundworms (Ascaris suum, adults and fourth-stage larvae; Ascarops strongylina, adults; Hyostrongylus rubidus, adults and fourth-stage larvae; Oesophagostomum spp., adults and fourth-stage larvae), kidneyworms (Stephanurus dentatus, adults and fourth-stage larvae), lungworms (Metastrongylus spp., adults), lice (Haematopinus suis) and mange mites (Sarcoptes scabiei var. suis).For reduction in the severity of swine mycoplasmal pneumonia caused by Mycoplasma hyopneumoniae. VFD (Effective 1/1/17)
Ivermectin, Lincomycin IVOMEC, LINCOMIX N141-054 Type C

For the treatment and control of gastrointestinal roundworms (Ascaris suum, adults and fourth-stage larvae; Ascarops strongylina, adults; Hyostrongylus rubidus, adults and fourth-stage larvae; Oesophagostomum spp., adults and fourth-stage larvae), kidneyworms (Stephanurus dentatus, adults and fourth-stage larvae), lungworms (Metastrongylus spp., adults), lice (Haematopinus suis) and mange mites (Sarcoptes scabiei var. suis).

Control of swine dysentery; for use in swine on premises with a history of swine dysentery, but where symptoms have not yet occurred.

VFD (Effective 1/1/17)
Ivermectin, Lincomycin IVOMEC, LINCOMIX N141-054 Type B

For the treatment and control of gastrointestinal roundworms (Ascaris suum, adults and fourth-stage larvae; Ascarops strongylina, adults; Hyostrongylus rubidus, adults and fourth-stage larvae; Oesophagostomum spp., adults and fourth-stage larvae), kidneyworms (Stephanurus dentatus, adults and fourth-stage larvae), lungworms (Metastrongylus spp., adults), lice (Haematopinus suis) and mange mites (Sarcoptes scabiei var. suis).

For the treatment and control of swine dysentery.

VFD (Effective 1/1/17)
Lincomycin LINCOMIX N097-505 Type C For reduction in the severity of swine mycoplasmal pneumonia caused by Mycoplasma hyopneumoniae. VFD (Effective 1/1/17)
Lincomycin LINCOMIX N097-505 Type B For the treatment and control of swine dysentery and the control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis. For reduction in the severity of swine mycoplasmal pneumonia caused by Mycoplasma hyopneumoniae. . VFD (Effective 1/1/17)
Lincomycin (Swine Ration L100) LINCOMIX N097-505 Type C For treatment of swine dysentery and the control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis. VFD (Effective 1/1/17)
Lincomycin (Swine Ration LC) LINCOMIX N097-505 Type C For control of swine dysentery and the control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis. VFD (Effective 1/1/17)
Lincomycin (Swine Ration L20) LINCOMIX N097-505 Type C For increase in rate of weight gain in growing-finishing swine. As of 1/1/17, this use is no longer approved
Lincomycin and Fenbendazole LINCOMIX, SAFE-GUARD N140-954 Type C FENBENDAZOLE IS INDICATED FOR THE REMOVAL OF:
Lungworms: Metastrongylus apri, Metastrongylus pudendotectus
Gastrointestinal worms: Adult and larvae (L3, L4 stages, liver, lung, intestinal forms) large roundworm (Ascaris suum); nodular worms (Oesophagostomum dentatum, O. quadrispinulatum); small stomach worm (Hyostrongylus rubidus); Adult and larvae (L2, 3, 4 stages - intestinal mucosal forms) whipworm (Trichuris suis)
Kidney worm: Adult and larvae Stephanurus dentatus.
LINCOMYCIN IS INDICATED FOR: for reduction in the severity of swine mycoplasma pneumonia caused by Mycoplasma hyopneumoniae.
VFD (Effective 1/1/17)
Lincomycin and Fenbendazole LINCOMIX, SAFE-GUARD N140-954 Type C FENBENDAZOLE IS INDICATED FOR THE REMOVAL OF:
Lungworms: Metastrongylus apri, Metastrongylus pudendotectus
Gastrointestinal worms: Adult and larvae (L3, L4 stages, liver, lung, intestinal forms) large roundworm (Ascaris suum); nodular worms (Oesophagostomum dentatum, O. quadrispinulatum); small stomach worm (Hyostrongylus rubidus); Adult and larvae (L2, 3, 4 stages - intestinal mucosal forms) whipworm (Trichuris suis)
Kidney worm: Adult and larvae Stephanurus dentatus.
LINCOMYCIN IS INDICATED FOR: treatment of swine dysentery.
VFD (Effective 1/1/17)
Lincomycin and Fenbendazole LINCOMIX, SAFE-GUARD N140-954 Type C

FENBENDAZOLE IS INDICATED FOR THE REMOVAL OF:
Lungworms: Metastrongylus apri, Metastrongylus pudendotectus
Gastrointestinal worms: Adult and larvae (L3, L4 stages, liver, lung, intestinal forms) large roundworm (Ascaris suum); nodular worms (Oesophagostomum dentatum, O. quadrispinulatum); small stomach worm (Hyostrongylus rubidus); Adult and larvae (L2, 3, 4 stages - intestinal mucosal forms) whipworm (Trichuris suis)
Kidney worm: Adult and larvae Stephanurus dentatus.

LINCOMYCIN IS INDICATED FOR: control of swine dysentery; for use in swine on premises with a history of swine dysentery, but where symptoms have not yet occurred.

VFD (Effective 1/1/17)
Lincomycin and Pyrantel tartrate BANMINTH, LINCOMIX N116-044 Type B For control of swine dysentery. Aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; aid in the prevention of establishment of nodular worm (Oesophagostomum spp.) infections of swine. VFD (Effective 1/1/17)
Lincomycin and Pyrantel tartrate BANMINTH, LINCOMIX N116-044 Type B For treatment of swine dysentery. Aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; aid in the prevention of establishment of nodular worm (Oesophagostomum spp.) infections of swine. VFD (Effective 1/1/17)
Lincomycin and Pyrantel tartrate BANMINTH, LINCOMIX N116-044 Type C For treatment and/or control of swine dysentery; for removal and control of large roundworm (Ascaris suum) and nodular worm (Oesophagostomum spp.) infections. VFD (Effective 1/1/17)
Lincomycin and Pyrantel tartrate BANMINTH, LINCOMIX N116-044 Type C For treatment and/or control of swine dysentery; for removal and control of large roundworm (Ascaris suum) and nodular worm (Oesophagostomum spp.) infections. VFD (Effective 1/1/17)
Lincomycin and Pyrantel tartrate BANMINTH, LINCOMIX N138-941 Type B For reduction in the severity of mycoplasmal pneumonia caused by Mycoplasma hyopneumoniae. Aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; aid in the prevention of establishment of nodular worm (Oesophagostomum spp) infections of swine when fed in accordance with directions for use. VFD (Effective 1/1/17)
Lincomycin and Pyrantel tartrate BANMINTH, LINCOMIX N138-941 Type C For reduction in the severity of mycoplasmal pneumonia caused by Mycoplasma hyopneumoniae. Aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; aid in the prevention of establishment of nodular worm (Oesophagostomum spp) infections of swine when fed in accordance with directions for use. VFD (Effective 1/1/17)
Neomycin Sulfate and Oxytetracycline NEO-TERRAMYCIN N094-975 Type B Treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis susceptible to oxytetracycline and treatment of bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin.
For breeding swine for control and treatment of Leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline
VFD (Effective 1/1/17)
Neomycin Sulfate and Oxytetracycline NEO-TERRAMYCIN N094-975 Type C Treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis susceptible to oxytetracycline and treatment of bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin.
For breeding swine for control and treatment of Leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline
VFD (Effective 1/1/17)
Neomycin Sulfate and Oxytetracycline NEO-OXY N138-939 Type B For increased rate of weight gain and improved feed efficiency....treatment and control of bacterial enteritis...and bacterial pneumonia...treatment and control of colibacillosis...control and treatment of leptospirosis... VFD (Effective 1/1/17)
Neomycin Sulfate and Oxytetracycline NEO-OXY N138-939 Type C For increased rate of weight gain and improved feed efficiency. As of 1/1/17, this use is no longer approved
Neomycin Sulfate and Oxytetracycline NEO-OXY N138-939 Type C For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis... VFD (Effective 1/1/17)
Oxytetracycline TERRAMYCIN N008-804 Type B

Treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis susceptible to oxytetracycline and treatment of bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline

For breeding swine for control and treatment of Leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline

VFD (Effective 1/1/17)
Oxytetracycline TERRAMYCIN N008-804 Type C

Treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis susceptible to oxytetracycline and treatment of bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline

For breeding swine for control and treatment of Leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline

VFD (Effective 1/1/17)
Oxytetracycline OXTC N095-143 Type B For swine for increased rate of weight gain and improved feed efficiency. As of 1/1/17, this use is no longer approved
Oxytetracycline OXTC N095-143 Type C For swine for increased rate of weight gain and improved feed efficiency. As of 1/1/17, this use is no longer approved
Oxytetracycline OXTC N095-143 Type B For swine for treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis susceptible to oxytetracycline and treatment of bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline.
For breeding swine for control and treatment of Leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline.
VFD (Effective 1/1/17)
Oxytetracycline OXTC N095-143 Type C For swine for treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis susceptible to oxytetracycline and treatment of bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline.
For breeding swine for control and treatment of Leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline.
VFD (Effective 1/1/17)
Oxytetracycline OTC N138-938 Type B For increased rate of weight gain and improved feed efficiency; treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida; control and treatment of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona. VFD (Effective 1/1/17)
Oxytetracycline OTC N138-938 Type C For increased rate of weight gain and improved feed efficiency. As of 1/1/17, this use is no longer approved
Oxytetracycline OTC N138-938 Type C For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida. VFD (Effective 1/1/17)
Oxytetracycline OTC N138-938 Type C For control and treatment of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline. VFD (Effective 1/1/17)
Pyrantel tartrate BAN-A-WORM N043-290 Type B

For the removal and control of large roundworm (Ascaris suum) and nodular worm (Oesophagostomum) infections in swine.

To aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; aid in the prevention of establishment of nodular worm (Oesophagostomum) infections in swine.

For the removal and control of large roundworm (Ascaris suum) infections in swine.

OTC
Pyrantel tartrate BAN-A-WORM N043-290 Type C

For the removal and control of large roundworm (Ascaris suum) and nodular worm (Oesophagostomum) infections in swine.

To aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; aid in the prevention of establishment of nodular worm (Oesophagostomum) infections in swine.

For the removal and control of large roundworm (Ascaris suum) infections in swine.

OTC
Tiamulin DENAGARD N139-472 Type B For control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis; control of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin; treatment of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin. OTC
Tiamulin DENAGARD N139-472 Type C For control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis and for control of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin; treatment of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin. OTC
Tiamulin DENAGARD N139-472 Type C - 35 g/ton For control of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to tiamulin. OTC
Tiamulin DENAGARD N139-472 Type C - 200 g/ton For control of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to tiamulin. OTC
Tiamulin DENAGARD N139-472 Type C For control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis. OTC
Tiamulin, Chlortetracycline DENAGARD, CTC N141-011 Type C For the control of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to tiamulin and for treatment of swine bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis sensitive to chlortetracycline and treatment of bacterial pneumonia caused by Pasteurella multocida sensitive to chlortetracycline. VFD (Effective 1/1/17)
Tiamulin, Chlortetracycline DENAGARD, PENNCHLOR A200-356 Type C For control of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to tiamulin and for treatment of swine bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis sensitive to chlortetracycline and treatment of bacterial pneumonia caused by Pasteurella multocida sensitive to chlortetracycline. VFD (Effective 1/1/17)
Tilmicosin PULMOTIL N141-064 Type C For the control of swine respiratory disease associated with Actinobacillus pleuropneumoniae and Pasteurella multocida. VFD
Tilmicosin PULMOTIL N141-064 Type B For the control of swine respiratory disease associated with Actinobacillus pleuropneumoniae and Pasteurella multocida. VFD
Tilmicosin TILMOVET A200-509 Type B For the control of swine respiratory disease associated with Actinobacillus pleuropneumoniae and Pasteurella multocida. VFD
Tilmicosin TILMOVET A200-509 Type C For the control of swine respiratory disease associated with Actinobacillus pleuropneumoniae and Pasteurella multocida. VFD
Tylosin TYLAN N012-491 Type B For treatment and control of swine dysentery associated with Brachyspira hyodysenteriae immediately after medicating with tylosin in drinking water. VFD (Effective 1/1/17)
Tylosin TYLAN N012-491 Type C For treatment and control of swine dysentery associated with Brachyspira hyodysenteriae immediately after medicating with tylosin in drinking water. VFD (Effective 1/1/17)
Tylosin TYLAN N012-491 Type B For control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis immediately after medicating with tylosin in drinking water. VFD (Effective 1/1/17)
Tylosin TYLAN N012-491 Type C For control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis immediately after medicating with tylosin in drinking water. VFD (Effective 1/1/17)
Tylosin TYLAN N012-491 Type B For control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Tylosin TYLAN N012-491 Type C For control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Tylosin TYLAN N012-491 Type B For control of swine dysentery associated with Brachyspira hyodysenteriae VFD (Effective 1/1/17)
Tylosin TYLAN N012-491 Type C For control of swine dysentery associated with Brachyspira hyodysenteriae VFD (Effective 1/1/17)
Tylosin TYLAN N012-491 Type B For reduction in severity of effects of atrophic rhinitis VFD (Effective 1/1/17)
Tylosin TYLAN N012-491 Type C For reduction in severity of effects of atrophic rhinitis VFD (Effective 1/1/17)
Tylosin TYLOVET A200-484 Type B For the reduction in severity of effects of atrophic rhinitis. VFD (Effective 1/1/17)
Tylosin TYLOVET A200-484 Type C For the reduction in severity of effects of atrophic rhinitis. VFD (Effective 1/1/17)
Tylosin TYLOVET A200-484 Type B For control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Tylosin TYLOVET A200-484 Type B For treatment and control of swine dysentery associated with Brachyspira hyodysenteriae immediately after medicating with tylosin in drinking water. VFD (Effective 1/1/17)
Tylosin TYLOVET A200-484 Type C For treatment and control of swine dysentery associated with Brachyspira hyodysenteriae immediately after medicating with tylosin in drinking water. VFD (Effective 1/1/17)
Tylosin TYLOVET A200-484 Type B For control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis immediately after medicating with tylosin in drinking water. VFD (Effective 1/1/17)
Tylosin TYLOVET A200-484 Type C For control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis immediately after medicating with tylosin in drinking water. VFD (Effective 1/1/17)
Tylosin TYLOVET A200-484 Type C For control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis. VFD (Effective 1/1/17)
Tylosin TYLOVET A200-484 Type B For control of swine dysentery associated with Brachyspira hyodysenteriae. VFD (Effective 1/1/17)
Tylosin TYLOVET A200-484 Type C For control of swine dysentery associated with Brachyspira hyodysenteriae. VFD (Effective 1/1/17)
Tylosin and Pyrantel TYLAN, BANMINTH N110-047 Type C For treatment and control of swine dysentery (vibrionic) immediately after medicating with tylosin in drinking water; aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; and as an aid in the prevention of establishment of nodular worm (Oesophagostomum) infections. VFD (Effective 1/1/17)
Tylosin and Pyrantel TYLAN, BANMINTH N110-047 Type C For prevention of swine dysentery (vibrionic); aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; and as aid in the prevention of establishment of nodular worm (Oesophagostumum) infections. VFD (Effective 1/1/17)
Tylosin and Pyrantel TYLAN, BANMINTH N110-047 Type C For prevention of swine dysentery (vibrionic); aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; and as an aid in the.
prevention of establishment of nodular worm (Oesophagostomum) infections.
VFD (Effective 1/1/17)
Tylosin and Sulfamethazine TYLAN, SULFA-G N041-275 Type B For reduction in the severity of effects of atrophic rhinitis; lowering the incidence and severity of Bordetella bronchiseptica rhinitis; prevention of swine dysentery associated with Brachyspira hyodysenteriae; control of swine pneumonias caused by bacterial pathogens (Pasteurella multocida and/or Arcanobacterium pyogenes);
Reducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci. Only the sulfamethazine portion of this combination is active in controlling jowl abscesses.
VFD (Effective 1/1/17)
Tylosin and Sulfamethazine TYLAN, SULFA-G N041-275 Type C Reducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci. Only the sulfamethazine portion of this combination is active in controlling jowl abscesses. VFD (Effective 1/1/17)
Tylosin and Sulfamethazine TYLAN, SULFA-G N041-275 Type C For prevention of swine dysentery associated with Brachyspira hyodysenteriae VFD (Effective 1/1/17)
Tylosin and Sulfamethazine TYLAN, SULFA-G N041-275 Type C For control of swine pneumonias caused by bacterial pathogens (Pasteurella multocida and/or Arcanobacterium pyogenes). VFD (Effective 1/1/17)
Tylosin and Sulfamethazine TYLAN, SULFA-G N041-275 Type C For lowering the incidence and severity of Bordetella bronchiseptica rhinitis VFD (Effective 1/1/17)
Tylosin and Sulfamethazine TYLAN, SULFA-G N041-275 Type C For reduction in the severity of effects of atrophic rhinitis. VFD (Effective 1/1/17)
Tylosin and Sulfamethazine TYLAN, SULFA-G N091-749 Type B For reduction in the severity of effects of atrophic rhinitis; lowering the incidence and severity of Bordetella bronchiseptica rhinitis; prevention of swine dysentery associated with Brachyspira hyodysenteriae; and control of swine pneumonias caused by bacterial pathogens (Pasteurella multocida and/or Arcanobacterium pyogenes.) VFD (Effective 1/1/17)
Tylosin and Sulfamethazine TYLAN, SULFA-G N091-749 Type C For lowering the incidence and severity of Bordetella bronchiseptica rhinitis. VFD (Effective 1/1/17)
Tylosin and Sulfamethazine TYLAN, SULFA-G N091-749 Type C Prevention of swine dysentery associated with Brachyspira hyodysenteriae. VFD (Effective 1/1/17)
Tylosin and Sulfamethazine TYLAN, SULFA-G N091-749 Type C For reduction in the severity of effects of atrophic rhinitis. VFD (Effective 1/1/17)
Tylosin and Sulfamethazine TYLAN, SULFA-G N091-749 Type C Control of swine pneumonias caused by bacterial pathogens (Pasteurella multocida and/or Arcanobacterium pyogenes.) VFD (Effective 1/1/17)
Tylvalosin AIVLOSIN N141-460 Type B Control of porcine proliferative enteropathy (FPE) associated with Lawsonia intracellularis infection in groups of swine in buildings experiencing an outbreak of PPE VFD
Tylvalosin AIVLOSIN N141-460 Type C Control of porcine proliferative enteropathy (FPE) associated with Lawsonia intracellularis infection in groups of swine in buildings experiencing an outbreak of PPE VFD
Virginiamycin STAFAC N091-467 Type B Increased rate of weight gain and improved feed efficiency; aid in the control of swine dysentery... for use in animals or on premises with a history of swine dysentery, but where symptoms have not yet occurred; treatment and control of swine dysentery. VFD (Effective 1/1/17)
Virginiamycin STAFAC N091-467 Type C Increased rate of weight gain and improved feed efficiency... As of 1/1/17, this use is no longer approved.
Virginiamycin STAFAC N091-467 Type C As an aid in the control of swine dysentery in swine weighing up to 120 lb.  For use in animals or on premises with a history of swine dysentery, but where symptoms have not yet occurred. VFD (Effective 1/1/17)
Virginiamycin STAFAC N091-467 Type C For treatment and control of swine dysentery in swine weighing up to 120 lb. VFD (Effective 1/1/17)
Virginiamycin STAFAC N091-467 Type C For treatment and control of swine dysentery in non-breeding swine weighing over 120 lb. VFD (Effective 1/1/17)
Virginiamycin STAFAC N091-467 Type C Increased rate of weight gain and improved feed efficiency... As of 1/1/17, this use is no longer approved.

Back to the top

Page Last Updated: 03/28/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English